Mircette
(desogestrel/ethinyl estradiol and ethinyl estradiol tablets USP)
Approved
Approval ID
a39bb616-9e84-4142-8450-824f88528906
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 31, 2022
Manufacturers
FDA
Teva Women's Health LLC
DUNS: 017038951
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51285-120
Application NumberANDA075863
Product Classification
M
Marketing Category
C73584
G
Generic Name
Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol
Product Specifications
Effective DateJanuary 31, 2022
FDA Product Classification